Buprenorphine Hydrochloride
Total Payments
$126,042
Transactions
25
Doctors
2
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $32,461 | 7 | 1 |
| 2018 | $68,169 | 13 | 2 |
| 2017 | $25,412 | 5 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125,972 | 20 | 99.9% |
| Travel and Lodging | $60.36 | 4 | 0.0% |
| Consulting Fee | $9.48 | 1 | 0.0% |
Ad
Manufacturing Companies
- Mylan Pharmaceuticals Inc. $93,568
- Mylan Inc. $32,461
- Mylan Specialty L.P. $13.67
Product Information
- Type Drug
- Total Payments $126,042
- Total Doctors 2
- Transactions 25
About Buprenorphine Hydrochloride
Buprenorphine Hydrochloride is a drug associated with $126,042 in payments to 2 healthcare providers, recorded across 25 transactions in the CMS Open Payments database. The primary manufacturer is Mylan Pharmaceuticals Inc..
Payment data is available from 2017 to 2020. In 2020, $32,461 was paid across 7 transactions to 1 doctors.
The most common payment nature for Buprenorphine Hydrochloride is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($125,972, 99.9% of total).